Pyng Medical Corp.

Pyng Medical Corp.

July 18, 2007 18:07 ET

Pyng Medical Featured on Business News Network

VANCOUVER, BRITISH COLUMBIA--(Marketwire - July 18, 2007) - Pyng Medical Corp. (TSX VENTURE:PYT) was featured today, 18 July 2007, on the Business News Network "Small Caps" show with hosts Andrew Bell and Lou Schizas, with guest Jay Taylor from New York City (

The stock market responded enthusiastically with the share price reaching a 52-week high of 95 cents, up from the opening price of 50 cents. 432,095 shares were traded, closing at 78 cents, a 39.3% increase over the prior day close.

"We are pleased to have this opportunity to tell our story for the wide audience that Business News Network provides," said David Christie, President and Chief Executive Officer. "With our business performing strongly, it is important to get the word out and we are pleased that the market responded favorably."

Pyng will release its third quarter financial report on SEDAR on July 30, 2007. An investor conference call is scheduled for July 31 at 10 am PDT.

About Pyng Medical Corp.

Pyng Medical Corp. is a world-leader in intraosseous infusion with its proprietary award-winning FAST1™ Intraosseous Infusion System. The FAST1™ is used extensively by the U.S. Department of Defense and by Emergency Medical Services around the globe.

Safe Harbour Statement; Forward-Looking Statements: This release may contain forward-looking statements based on management's expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company's strategy for growth, product development, market position, expected expenditures and financial results are forward-looking statements. Some of the forward-looking statements may be identified by words like "expects", "anticipates", "plans", "intends", "projects", "indicates", and similar expressions. These statements are not guarantees of future performance and involve a number of risks, uncertainties and assumptions. Many factors, including those discussed more fully elsewhere in this release and in documents which may be filed with the British Columbia Securities Commission, the Alberta Securities Commission, the Ontario Securities Commission, the TSX Venture Exchange, as well as other USA Commissions, could cause results to differ materially from those stated. These factors include, but are not limited to changes in the laws, regulations, policies and economic conditions, including inflation, interest and foreign currency exchange rates, of countries in which the Company does business; competitive pressures; successful integration of structural changes, including restructuring plans, acquisitions, divestitures and alliances; cost of raw material, research and development of new products, including regulatory approval and market acceptance; and seasonality of sales in some products.

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Contact Information

  • Pyng Medical Corp.
    David Christie
    (604) 303-7964